News tagged with 'Zometa'

New research suggests that adding Zometa (zoledronic acid) to post-surgery hormone therapy, reduces the risk of breast cancer recurrence or death in premenopausal women by 36 percent compared to hormone therapy alone.

New research presented at the San Antonio Breast Cancer Symposium suggests adding the bone-strengthening drug Zometa to chemotherapy shrinks breast tumors more than chemo alone, helping more women to avoid mastectomy.

Bisphosphonates, are a class of drug used to treat osteoporosis that slows or stops the reabsorption of bone, which are being linked to a condition in which jawbone tissue dies.